Pipeline

Drug Candidate
Lead Selection
Pre-Clinical Testing
IND-Enabling Studies
Phase I
Phase II
Phase III
Gene Therapy
B-Cell Lymphoma
T-Cell Lymphoma
MRI-1867
Systemic Sclerosis (Orphan Drug Indication)